Posted On:
September 28, 2009
Januvia and Janumet Diabetes Drug Dangers
On Friday, the FDA issued a warning to healthcare providers about diabetes drugs Januvia and Janumet, manufactured by Merck & Co., Inc. These drugs are in the class known as sitaglipins, and are designed to help treat patients with type-2 diabetes and type-2 diabetes mellitus. Post-marketing surveillance reveals that the drugs may be associated with acute pancreatitis after reports of 88 patients experiencing that condition between October 2006 and February 2009.
A lot of drugs are linked with acute pancreatitis, these days (see Seroquel and Byetta). Symptoms to look for include:
- Upper abdominal pain that may radiate to the back
- Abdominal pain, especially after eating
- Vomiting and Nausea
- Abdominal tenderness
For more information, see our main Januvia and Janumet Diabetes Drug website.
